From: A comparability study of 5 commercial KRAS tests
All Patients (N = 40)
Sex, n (%)
Men
14 (35)
Women
20 (50)
Missing
6 (15)
Median age,* yrs (range)
67 (35-94)
Primary diagnosis, n (%)
Colon adenocarcinoma
36 (90)
Rectal adenocarcinoma
3 (7.5)
Rectal carcinoma
1 (2.5)